BRYNJELSEN SEAN - Insider Non-Derivative Transactions at Eton Pharmaceuticals, Inc. (ETON) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 12, 2025, BRYNJELSEN SEAN's relationship to Eton Pharmaceuticals, Inc. (ETON) is Director,Officer,TenPercentOwner (President & CEO), and currently has 2,894,281 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ETON insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

BRYNJELSEN SEAN - Insider Non-Derivative Transactions of ETON Common Stock

BRYNJELSEN SEAN - Insider Non-Derivative Transactions at ETON

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	F -- (Common Stock)	6732	16.83	2894281
Jun 6, 2025	Sell -- (Common Stock)	70000	16.81	2873513
Jun 5, 2025	Sell -- (Common Stock)	70000	17	2943513
Jun 4, 2025	Sell -- (Common Stock)	400	19.02	3013513
Jun 4, 2025	Sell -- (Common Stock)	8655	18.38	3013913
Jun 4, 2025	Sell -- (Common Stock)	60945	17.38	3022568